News – Page 1046 – Endpoints News

J&J's blockbuster hopeful erdafitinib gets 'breakthrough' moniker

8 years ago

Eli Lilly gets a date with FDA experts for once-rejected rheumatoid arthritis drug baricitinib

8 years ago

China stocks the new trend? Loncar launches index

8 years ago

Alexion's successor to Soliris hits co-primary endpoints in a pivotal, but can't surpass the big blockbuster

8 years ago

Hinting at an IPO and big things ahead for synthetic lethality, preclinical Ideaya touts a $94M round

8 years ago

Swapping stock and cash, Ionis turns to closely-controlled Akcea for a deal on spurned drug inotersen

8 years ago

The biotech IPO party rocks on with $120M raise for I/O player Arcus Biosciences

8 years ago

FDA slaps a hold on Solid Bio's gene therapy for Duchenne MD in wake of safety alert

8 years ago

PureTech Health snags $100M to fund affiliates; PolyPid takes a third stab at IPO

8 years ago

Bye CFDA: China's drug regulator to take new shape in major government restructuring

8 years ago

Tracking a successful DLBCL assault in Phase II, MorphoSys sets out to seize quick OK for MOR208

8 years ago

Lousy year for shareholders, but Allergan CEO Brent Saunders sprints past Gorsky, Gonzalez with $32M pay package

8 years ago

'Right-to-try' bill fails to muster votes, dies in the House (for now)

8 years ago

0-for-3 in PhIII: Auris’ late-stage changeup fails to save tinnitus drug from another disaster

8 years ago

Endocrine experts at Crinetics bag $63.5M to push R&D on an experimental pill for acromegaly

8 years ago

An immunotherapy pill for psoriasis? Escalier gets $19M Series B to tackle R&D

8 years ago

FDA gives priority review to new Keytruda sBLA; AstraZeneca's Pearl signs asthma development pact with Avillion

8 years ago

From drugmaker to drug manager: Ex-GSK chief Andrew Witty jumps to the helm of giant Optum

8 years ago

With rival to anti-TNF injectables, Protalix reports positive PhII data in ulcerative colitis

8 years ago

AbbVie sweeps back-to-back PhIIIs for uterine fibroid patients, adding to elagolix's blockbuster rep

8 years ago

Halted in US by FDA hold, Bellicum buoyed by some positive numbers from its European T cell study for pediatric AML

8 years ago

Teva calls off CGRP drug discovery and development pact, returns preclinical asset to Sosei

8 years ago

Proteostasis stock soars on cystic fibrosis breakthrough status

8 years ago

Patient death forces FDA to slap a hold on study using combo from Advaxis, AstraZeneca -- biotech's shares plunge

8 years ago

First page Previous page 1043 1044 104510461047 1048 1049 Next page Last page